Panacea Life Sciences Holdings, Inc. Stock

Equities

PLSH

US69810P1093

Pharmaceuticals

Market Closed - OTC Markets 01:09:14 2024-04-26 pm EDT 5-day change 1st Jan Change
0.19 USD +37.29% Intraday chart for Panacea Life Sciences Holdings, Inc. +47.98% +26.67%
Sales 2022 1.63M Sales 2023 2.38M Capitalization 2.65M
Net income 2022 -9M Net income 2023 -8M EV / Sales 2022 11.6 x
Net Debt 2022 17.85M Net Debt 2023 21.53M EV / Sales 2023 10.1 x
P/E ratio 2022
-0.11 x
P/E ratio 2023
-0.31 x
Employees 40
Yield 2022 *
-
Yield 2023
-
Free-Float 42.59%
More Fundamentals * Assessed data
Dynamic Chart
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc. CI
Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc. CI
Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million. CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million. CI
Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom. CI
Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida. CI
Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
Panacea Life Sciences Holdings, Inc. entered into a letter of intent to acquire N7 Enterprises, Inc. for $2.7 million. CI
Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
More news
1 day+37.29%
1 week+47.98%
Current month-3.89%
1 month+1.12%
3 months+57.02%
6 months+2.15%
Current year+26.67%
More quotes
1 week
0.14
Extreme 0.1384
0.19
1 month
0.10
Extreme 0.096
0.35
Current year
0.10
Extreme 0.096
0.35
1 year
0.10
Extreme 0.096
0.63
3 years
0.04
Extreme 0.0421
5.57
5 years
0.04
Extreme 0.0421
5.57
10 years
0.04
Extreme 0.0421
5.57
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 21-06-29
President - 18-12-31
Chief Tech/Sci/R&D Officer 59 16-12-31
Members of the board TitleAgeSince
Chief Executive Officer 67 21-06-29
Director/Board Member 66 20-04-28
More insiders
Date Price Change Volume
24-04-26 0.19 +37.29% 858
24-04-23 0.1384 -19.32% 400
24-04-22 0.1715 +33.58% 100
24-04-19 0.1284 -32.42% 15,665
24-04-18 0.19 +7.27% 100

Delayed Quote OTC Markets, April 26, 2024 at 01:09 pm EDT

More quotes
Panacea Life Sciences Holdings, Inc. is a holding company organized as a plant-based natural health ingredient and product company. It specializes in the development, manufacturing, research, and distribution of products with natural health and wellness market segment for both humans and animals. The Company’s subsidiary, Panacea Life Sciences, Inc. (PLS) is engaged in the production, distribution, research, and manufacturing of nutraceuticals, cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products. The Company also offers natural remedies within its branded product lines for every aspect of life, including PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life. It also operates 51,000 square foot current good manufacturing practice (cGMP) facility located in Golden, Colorado. The Company, through Panacea Life Sciences Holdings, Inc., manages six retail locations and a distribution center situated in the Tampa, Florida area.
More about the company